JNJ

J&J Seeks Approval for Darzalex in Expanded Patient Group
J&J Seeks Approval for Darzalex in Expanded Patient Group
Yahoo/Zacks.com
JNJ
Darzalex
Multiple Myeloma
FDA
Flag link:
J&J chief Alex Gorsky suffers a big drop in compensation, but still comes out way ahead of most major league CEOs
J&J chief Alex Gorsky suffers a big drop in compensation, but still comes out way ahead of most major league CEOs
Endpoints
JNJ
Alex Gorsky
Pharma CEOs
executive pay
Flag link:
Johnson & Johnson chalks up another talc loss with $29M mesothelioma verdict
Johnson & Johnson chalks up another talc loss with $29M mesothelioma verdict
Fierce Pharma
JNJ
Flag link:
Janssen, Scripps discover small molecule for flu
Janssen, Scripps discover small molecule for flu
BioCentury
JNJ
Janssen
Scripps Research Institute
Flu
influenza
small molecule drugs
Flag link:
J&J prices ketamine-like depression treatment at $590-$885 for two doses
J&J prices ketamine-like depression treatment at $590-$885 for two doses
Reuters
JNJ
Spravato
depression
drug pricing
esketamine
Flag link:
Monthly shots control HIV as well as daily pills in two big studies
Monthly shots control HIV as well as daily pills in two big studies
Stat
HIV
AIDS
JNJ
Janssen
ViiV Healthcare
cabotegravir
Edurant
Flag link:
FDA approves Janssen's fast-acting depression therapy esketamine
FDA approves Janssen's fast-acting depression therapy esketamine
BioCentury
FDA
Spravato
esketamine
Janssen
JNJ
major depression
Flag link:
Bayer files prostate cancer drug darolutamide in Japan
Bayer files prostate cancer drug darolutamide in Japan
Pharmaforum
Bayer
prostate cancer
darolutamide
Japan
JNJ
Pfizer
Astellas
Flag link:
Novartis Sues Janssen Over False Advertisements for Psoriasis Drug
Novartis Sues Janssen Over False Advertisements for Psoriasis Drug
RAPS.org
Novartis
Janssen
JNJ
psoriasis
false advertising
Tremfya
Flag link:
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs
Yahoo/Benzinga
IPOs
biotech
JNJ
Janssen
esketamine
Shockwave Medical
earnings
Sensen Bio
MyoKardia
Flag link:
Johnson & Johnson keeps the heat on Tremfya's rivals with at-home injector nod
Johnson & Johnson keeps the heat on Tremfya's rivals with at-home injector nod
Fierce Pharma
JNJ
Janssen
Tremfya
psoriasis
Novartis
Cosentyx
Eli Lilly
Taltz
Flag link:
J&J bags option on AdoRx lung cancer drugs
J&J bags option on AdoRx lung cancer drugs
Fierce Biotech
JNJ
AdoRx
lung cancer
drug development
Flag link:
Trial Lawyers Are Paying Millions To A Handful Of Experts Necessary To Push Their Talc Cases
Trial Lawyers Are Paying Millions To A Handful Of Experts Necessary To Push Their Talc Cases
Forbes
JNJ
legal
Flag link:
J&J Earns Spot in Fortune’s Top 50 Most Respected Companies
J&J Earns Spot in Fortune’s Top 50 Most Respected Companies
BioSpace
JNJ
Fortune
Flag link:
The fighter, the saint, and the odd man out: the executives who will defend pharma before Congress
The fighter, the saint, and the odd man out: the executives who will defend pharma before Congress
Stat
drug pricing
US Congress
Donald Trump
Richard Gonzalez
AbbVie
Ken Frazier
Merck
JNJ
Jennifer Taubert
Olivier Brandicourt
Sanofi
Pascal Soriot
AstraZeneca
Giovanni Caforio
Bristol-Myers Squibb
Albert Bourla
Pfizer
Flag link:
J&J Hit With Federal Subpoenas Over Baby Powder Contamination Allegations
J&J Hit With Federal Subpoenas Over Baby Powder Contamination Allegations
BioSpace
JNJ
Flag link:
Morphic bags J&J as second big pharma partner for oral integrins
Morphic bags J&J as second big pharma partner for oral integrins
Fierce Biotech
JNJ
AbbVie
Morphic Therapeutic
small-molecule integrins
Flag link:
Pfizer, Merck, J&J well-positioned for M&A and Biogen and BioMarin are prime targets: report
Pfizer, Merck, J&J well-positioned for M&A and Biogen and BioMarin are prime targets: report
Fierce Pharma
M&A
oncology
neurology
Rare Diseases
Pfizer
Merck
JNJ
Biogen
Biomarin
Flag link:
The psychiatry field is buzzing with anticipation — and hesitation — about esketamine for depression
The psychiatry field is buzzing with anticipation — and hesitation — about esketamine for depression
Stat
major depression
esketamine
JNJ
FDA
psychiatrists
Flag link:
Auris acquisition could prompt more mega VC rounds
Auris acquisition could prompt more mega VC rounds
EP Vantage
venture capital
JNJ
Auris Health
devices
Flag link:

Pages